Matthew O'Brien
Stock Analyst at Piper Sandler
(0.21)
# 4,618
Out of 5,060 analysts
1279
Total ratings
39.8%
Success rate
-4.3%
Average return
Main Sectors:
Stocks Rated by Matthew O'Brien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OBIO Orchestra BioMed Holdings | Reiterated: Buy | $10 → $12 | $5.45 | +120.18% | 11 | Oct 15, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $65 → $60 | $44.39 | +35.17% | 62 | Oct 14, 2026 | |
| MDT Medtronic | Reiterated: Hold | $85 | $94.75 | -10.29% | 64 | Oct 14, 2026 | |
| KMTS Kestra Medical Technologies | Reiterated: Buy | $30 | $27.24 | +10.13% | 9 | Oct 5, 2026 | |
| TMDX TransMedics Group | Reiterated: Buy | $100 | $70.78 | +41.28% | 43 | Oct 5, 2026 | |
| SI Shoulder Innovations | Reiterated: Buy | $25 | $18.09 | +38.20% | 6 | Sep 28, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Hold | $4 | $1.30 | +207.69% | 25 | Sep 22, 2026 | |
| ATRC AtriCure | Rated: Buy | $50 → $60 | $56.07 | +7.01% | 43 | Aug 27, 2026 | |
| HTFL HeartFlow | Reiterated: Buy | $38 → $45 | $48.29 | -6.81% | 5 | Aug 14, 2026 | |
| TELA TELA Bio | Reiterated: Hold | $1 | $0.975 | +2.56% | 27 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $76.71 | +30.36% | 56 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $16.24 | +103.20% | 35 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $13.41 | +34.23% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $10.46 | +33.84% | 38 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $25 | $21.95 | +13.90% | 30 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $25 | $17.57 | +42.29% | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $19.68 | +27.03% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $97 → $127 | $126.70 | +0.24% | 15 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 → $95 | $86.04 | +10.41% | 67 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $420 → $390 | $294.66 | +32.36% | 54 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $16.39 | +22.03% | 12 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $39 → $45 | $46.72 | -3.68% | 42 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 | $141.10 | +48.83% | 38 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $17.49 | -8.52% | 2 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.099 | +2,930.30% | 1 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $330 → $374 | $320.86 | +16.56% | 18 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $94.98 | n/a | 42 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $8.28 | n/a | 24 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $21.27 | n/a | 12 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $245 → $140 | $130.43 | n/a | 26 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $11 | $13.04 | n/a | 20 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 → $180 | $164.84 | n/a | 62 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $4.5 → $2 | $2.55 | n/a | 26 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 → $3 | $0.429 | n/a | 7 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $44 | $13.21 | n/a | 38 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $11 | $0.794 | n/a | 7 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $90 | $0.0002 | n/a | 15 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $10 | $1.89 | n/a | 24 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $82 | $25.28 | n/a | 16 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $79 | $89.20 | n/a | 25 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $22.52 | n/a | 14 | Jul 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $3.00 | n/a | 6 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $370 → $435 | $57.94 | n/a | 30 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $73 | $77.58 | n/a | 38 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $7 | $0.000001 | n/a | 8 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $258 → $345 | $147.31 | n/a | 35 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $600 → $633 | $426.70 | n/a | 27 | Sep 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $3 | $6.00 | n/a | 3 | Jan 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $4.43 | n/a | 9 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 → $96 | $6.25 | n/a | 8 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $69 | $8.57 | n/a | 9 | Aug 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $70 | $238.97 | n/a | 8 | Aug 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.2867 | n/a | 2 | Aug 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.98 | n/a | 2 | May 8, 2012 |
Orchestra BioMed Holdings
Oct 15, 2026
Reiterated: Buy
Price Target: $10 → $12
Current: $5.45
Upside: +120.18%
Boston Scientific
Oct 14, 2026
Reiterated: Buy
Price Target: $65 → $60
Current: $44.39
Upside: +35.17%
Medtronic
Oct 14, 2026
Reiterated: Hold
Price Target: $85
Current: $94.75
Upside: -10.29%
Kestra Medical Technologies
Oct 5, 2026
Reiterated: Buy
Price Target: $30
Current: $27.24
Upside: +10.13%
TransMedics Group
Oct 5, 2026
Reiterated: Buy
Price Target: $100
Current: $70.78
Upside: +41.28%
Shoulder Innovations
Sep 28, 2026
Reiterated: Buy
Price Target: $25
Current: $18.09
Upside: +38.20%
CVRx, Inc.
Sep 22, 2026
Reiterated: Hold
Price Target: $4
Current: $1.30
Upside: +207.69%
AtriCure
Aug 27, 2026
Rated: Buy
Price Target: $50 → $60
Current: $56.07
Upside: +7.01%
HeartFlow
Aug 14, 2026
Reiterated: Buy
Price Target: $38 → $45
Current: $48.29
Upside: -6.81%
TELA Bio
Aug 11, 2026
Reiterated: Hold
Price Target: $1
Current: $0.975
Upside: +2.56%
Aug 7, 2026
Reiterated: Buy
Price Target: $100
Current: $76.71
Upside: +30.36%
Aug 7, 2026
Reiterated: Buy
Price Target: $33
Current: $16.24
Upside: +103.20%
Aug 6, 2026
Reiterated: Buy
Price Target: $18
Current: $13.41
Upside: +34.23%
Aug 5, 2026
Reiterated: Buy
Price Target: $14
Current: $10.46
Upside: +33.84%
Aug 5, 2026
Reiterated: Buy
Price Target: $22 → $25
Current: $21.95
Upside: +13.90%
Aug 5, 2026
Reiterated: Buy
Price Target: $35 → $25
Current: $17.57
Upside: +42.29%
Aug 4, 2026
Reiterated: Buy
Price Target: $25
Current: $19.68
Upside: +27.03%
Aug 3, 2026
Downgraded: Hold
Price Target: $97 → $127
Current: $126.70
Upside: +0.24%
Jul 31, 2026
Reiterated: Buy
Price Target: $88 → $95
Current: $86.04
Upside: +10.41%
Jul 31, 2026
Reiterated: Buy
Price Target: $420 → $390
Current: $294.66
Upside: +32.36%
Jul 30, 2026
Reiterated: Buy
Price Target: $20
Current: $16.39
Upside: +22.03%
Jul 30, 2026
Reiterated: Hold
Price Target: $39 → $45
Current: $46.72
Upside: -3.68%
Jun 15, 2026
Reiterated: Buy
Price Target: $210
Current: $141.10
Upside: +48.83%
Jun 4, 2026
Reiterated: Hold
Price Target: $16
Current: $17.49
Upside: -8.52%
Apr 14, 2026
Initiated Coverage: Buy
Price Target: $3
Current: $0.099
Upside: +2,930.30%
Jan 15, 2026
Downgraded: Hold
Price Target: $330 → $374
Current: $320.86
Upside: +16.56%
Oct 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $94.98
Upside: n/a
May 9, 2025
Reiterated: Hold
Price Target: $3.5
Current: $8.28
Upside: n/a
May 8, 2025
Reiterated: Hold
Price Target: $16
Current: $21.27
Upside: n/a
Feb 28, 2025
Downgraded: Hold
Price Target: $245 → $140
Current: $130.43
Upside: n/a
Feb 14, 2025
Reiterated: Hold
Price Target: $12 → $11
Current: $13.04
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $140 → $180
Current: $164.84
Upside: n/a
Aug 9, 2024
Rated: Hold
Price Target: $4.5 → $2
Current: $2.55
Upside: n/a
Nov 10, 2023
Reiterated: Hold
Price Target: $3.5 → $3
Current: $0.429
Upside: n/a
Jun 26, 2023
Reiterated: Hold
Price Target: $55 → $44
Current: $13.21
Upside: n/a
Nov 14, 2022
Reiterated: Buy
Price Target: $9 → $11
Current: $0.794
Upside: n/a
Nov 14, 2022
Reiterated: Buy
Price Target: $10 → $90
Current: $0.0002
Upside: n/a
Nov 9, 2021
Reiterated: Buy
Price Target: $12 → $10
Current: $1.89
Upside: n/a
Sep 2, 2021
Reiterated: Hold
Price Target: $82
Current: $25.28
Upside: n/a
Jul 30, 2021
Reiterated: Buy
Price Target: $62 → $79
Current: $89.20
Upside: n/a
Jul 6, 2021
Reiterated: Buy
Price Target: $70
Current: $22.52
Upside: n/a
Mar 23, 2021
Reiterated: Hold
Price Target: $3.5
Current: $3.00
Upside: n/a
Feb 11, 2021
Reiterated: Buy
Price Target: $370 → $435
Current: $57.94
Upside: n/a
Jan 12, 2021
Reiterated: Buy
Price Target: $70 → $73
Current: $77.58
Upside: n/a
Jan 12, 2021
Reiterated: Buy
Price Target: $4 → $7
Current: $0.000001
Upside: n/a
Jul 23, 2020
Reiterated: Buy
Price Target: $258 → $345
Current: $147.31
Upside: n/a
Sep 25, 2019
Reiterated: Buy
Price Target: $600 → $633
Current: $426.70
Upside: n/a
Jan 7, 2018
Reiterated: Buy
Price Target: $10 → $3
Current: $6.00
Upside: n/a
Dec 13, 2017
Reiterated: Buy
Price Target: $18
Current: $4.43
Upside: n/a
Nov 7, 2017
Reiterated: Hold
Price Target: $90 → $96
Current: $6.25
Upside: n/a
Aug 9, 2017
Reiterated: Buy
Price Target: $73 → $69
Current: $8.57
Upside: n/a
Aug 2, 2017
Reiterated: Hold
Price Target: $65 → $70
Current: $238.97
Upside: n/a
Aug 14, 2014
Reiterated: Buy
Price Target: n/a
Current: $0.2867
Upside: n/a
May 8, 2012
Downgraded: Hold
Price Target: n/a
Current: $8.98
Upside: n/a